Drug profile · INN
griseofulvin, microcrystalline
GRIFULVIN V
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
griseofulvin, microcrystalline (GRIFULVIN V) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN griseofulvin, microcrystalline
Brand GRIFULVIN V
Route ORAL
Formulation CAPSULE
Related patents
Search patents →Frequently asked questions
What is griseofulvin, microcrystalline?
griseofulvin, microcrystalline (GRIFULVIN V) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for griseofulvin, microcrystalline?
GRIFULVIN V is a marketed brand name for griseofulvin, microcrystalline. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of griseofulvin, microcrystalline?
griseofulvin, microcrystalline has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.